Clinical Trial Update: First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing first-line radiofrequency ablation to antiarrhythmic drugs for atrial fibrillation has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Radiofrequency ablation (radiofrequency energy)
• antiarrhythmic drugs

Snippet

Sponsor: Population Health Research Institute | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2020-01-31